New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism
出版年份 2019 全文链接
标题
New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism
作者
关键词
-
出版物
Expert Review of Clinical Pharmacology
Volume 12, Issue 12, Pages 1081-1090
出版商
Informa UK Limited
发表日期
2019-11-14
DOI
10.1080/17512433.2019.1693256
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
- (2019) Hakon Blomstrand et al. BMC CANCER
- Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology
- (2019) Giovanni Ponti et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- miR-142-3p inhibits aerobic glycolysis and cell proliferation in hepatocellular carcinoma via targeting LDHA
- (2018) Shengni Hua et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma
- (2018) Yuting He et al. MOLECULAR CARCINOGENESIS
- Therapeutic developments in pancreatic cancer: current and future perspectives
- (2018) John P. Neoptolemos et al. Nature Reviews Gastroenterology & Hepatology
- Increased Lactate in Gastric Cancer Tumor-Infiltrating Lymphocytes Is Related to Impaired T Cell Function Due to miR-34a Deregulated Lactate Dehydrogenase A
- (2018) Wang Ping et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Clinical update on K-Ras targeted therapy in gastrointestinal cancers
- (2018) Shubham Pant et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
- (2018) José Marrugo-Ramírez et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-323a-3p suppressed the glycolysis of osteosarcoma via targeting LDHA
- (2018) Hanwen Chen et al. Human Cell
- Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer
- (2017) Daniela Massihnia et al. Journal of Hematology & Oncology
- MiR-449a Suppresses LDHA-Mediated Glycolysis to Enhance the Sensitivity of Non-Small Cell Lung Cancer Cells to Ionizing Radiation
- (2017) Liang Li et al. ONCOLOGY RESEARCH
- Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) to increase radiosensitivity of human pancreatic cancer (PAC) cell lines proficient in homology-directed repair (HDR).
- (2017) Maeve A. Lowery et al. JOURNAL OF CLINICAL ONCOLOGY
- Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).
- (2017) Edward Samuel James et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
- (2017) Hidekazu Hiramoto et al. Scientific Reports
- Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective
- (2016) Joseph Ciccolini et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis
- (2016) Camille Lehuédé et al. CANCER RESEARCH
- On the pharmacogenetics of non-small cell lung cancer treatment
- (2016) Mariacarmela Santarpia et al. Expert Opinion on Drug Metabolism & Toxicology
- First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors
- (2016) Caterina Vivaldi et al. INTERNATIONAL JOURNAL OF CANCER
- Sensitization of hepatocellular carcinoma cells to irradiation by miR-34a through targeting lactate dehydrogenase-A
- (2016) XIAOGANG LI et al. Molecular Medicine Reports
- Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling
- (2016) J Li et al. ONCOGENE
- Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
- (2016) P. Lito et al. SCIENCE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Downregulating microRNA-144 mediates a metabolic shift in lung cancer cells by regulating GLUT1 expression
- (2016) MIN LIU et al. Oncology Letters
- MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulatingPTENandPDCD4
- (2016) Xueju Wei et al. Cancer Medicine
- Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma
- (2016) Hweixian Leong Penny et al. OncoImmunology
- Time and Circumstances: Cancer Cell Metabolism at Various Stages of Disease Progression
- (2016) Georg F. Weber Frontiers in Oncology
- The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
- (2016) Xiangsheng Xiao et al. Scientific Reports
- Prognostic role of lactate dehydrogenase in solid tumors: A systematic review and meta-analysis of 76 studies
- (2015) Fausto Petrelli et al. ACTA ONCOLOGICA
- Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
- (2015) N. V. Rajeshkumar et al. CANCER RESEARCH
- PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
- (2015) Fanny Dupuy et al. Cell Metabolism
- Metabolic Dependencies in RAS-Driven Cancers
- (2015) A. C. Kimmelman CLINICAL CANCER RESEARCH
- SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
- (2015) M. Hidalgo et al. CLINICAL CANCER RESEARCH
- Bioactive heterocycles containing endocyclic N-hydroxy groups
- (2015) Reshma Rani et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met
- (2015) Fengming Lan et al. JOURNAL OF NEUROCHEMISTRY
- Pancreatic cancer: from state-of-the-art treatments to promising novel therapies
- (2015) Ignacio Garrido-Laguna et al. Nature Reviews Clinical Oncology
- Targeting cancer cell metabolism in pancreatic adenocarcinoma
- (2015) Romain Cohen et al. Oncotarget
- Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells
- (2015) Keita Shibuya et al. Oncotarget
- Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma
- (2014) D. Propper et al. ANNALS OF ONCOLOGY
- Role of MicroRNAs in the Warburg Effect and Mitochondrial Metabolism in Cancer
- (2014) Li-Hui Jin et al. Asian Pacific Journal of Cancer Prevention
- Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
- (2014) E Van Cutsem et al. BRITISH JOURNAL OF CANCER
- Targeting Lactate Dehydrogenase-A Inhibits Tumorigenesis and Tumor Progression in Mouse Models of Lung Cancer and Impacts Tumor-Initiating Cells
- (2014) Han Xie et al. Cell Metabolism
- Stromal MicroRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancer
- (2014) Timothy R. Donahue et al. JOURNAL OF SURGICAL ONCOLOGY
- Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil
- (2014) XIANGYONG LI et al. Molecular Medicine Reports
- miR-211 Modulates Gemcitabine Activity Through Downregulation of Ribonucleotide Reductase and Inhibits the Invasive Behavior of Pancreatic Cancer Cells
- (2014) Mina Maftouh et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- KRAS: feeding pancreatic cancer proliferation
- (2014) Kirsten L. Bryant et al. TRENDS IN BIOCHEMICAL SCIENCES
- Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia
- (2013) M Maftouh et al. BRITISH JOURNAL OF CANCER
- Stromal expression of SPARC in pancreatic adenocarcinoma
- (2013) Cindy Neuzillet et al. CANCER AND METASTASIS REVIEWS
- Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer
- (2013) Krushna C. Patra et al. CANCER CELL
- Dual Targeting of the Warburg Effect with a Glucose-Conjugated Lactate Dehydrogenase Inhibitor
- (2013) Emilia C. Calvaresi et al. CHEMBIOCHEM
- Roles for KRAS in Pancreatic Tumor Development and Progression
- (2013) Marina Pasca di Magliano et al. GASTROENTEROLOGY
- Therapeutic Advances in Pancreatic Cancer
- (2013) Andrew Scott Paulson et al. GASTROENTEROLOGY
- Exploiting the bad eating habits of Ras-driven cancers
- (2013) E. White GENES & DEVELOPMENT
- Mini-review on Glycolysis and Cancer
- (2013) M. Akram JOURNAL OF CANCER EDUCATION
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma
- (2013) Hemchandra Mahaseth et al. PANCREAS
- Tumor heterogeneity in the clinic: is it a real problem?
- (2013) Filip Janku Therapeutic Advances in Medical Oncology
- Metabolic changes in cancer: beyond the Warburg effect
- (2012) W. Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- miR-17-5p Inhibitor Enhances Chemosensitivity to Gemcitabine Via Upregulating Bim Expression in Pancreatic Cancer Cells
- (2012) Hai-jiao Yan et al. DIGESTIVE DISEASES AND SCIENCES
- High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer
- (2012) Elisa Giovannetti et al. PLoS One
- MicroRNA Expression as a Predictive Marker for Gemcitabine Response after Surgical Resection of Pancreatic Cancer
- (2011) Kenoki Ohuchida et al. ANNALS OF SURGICAL ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
- (2011) M. Preis et al. CLINICAL CANCER RESEARCH
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNAmiR-17-5pis overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion
- (2010) Jun Yu et al. CANCER BIOLOGY & THERAPY
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation
- (2010) Valentina Boni et al. MOLECULAR CANCER THERAPEUTICS
- Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
- (2010) Jin-Hyeok Hwang et al. PLoS One
- Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
- (2010) A. Le et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells
- (2009) Y. Li et al. CANCER RESEARCH
- Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
- (2009) David Cunningham et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started